Jiangsu CoWin Biotech Revenue

In the year 2025, Jiangsu CoWin Biotech had annual revenue of 193.05M CNY with 53.36% growth. Jiangsu CoWin Biotech had revenue of 53.47M in the quarter ending December 31, 2025, with 93.80% growth.

Revenue

193.05M

Revenue Growth

+53.36%

P/S Ratio

13.40

Revenue / Employee

231.75K

Employees

770

Market Cap

2.59B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	193.05M	67.17M	53.36%
Dec 31, 2024	125.88M	-45.47M	-26.54%
Dec 31, 2023	171.34M	-350.26M	-67.15%
Dec 31, 2022	521.60M	183.14M	54.11%
Dec 31, 2021	338.46M	105.25M	45.13%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Zhejiang East Asia Pharmaceutical	831.56M
Shanghai Serum Bio-Technology	196.21M
Guiyang Xintian Pharmaceutical	755.34M
Hubei Goto Biopharm	626.28M
Jiangsu Gdk Biological Technology	113.23M
Shandong Sito Bio-technology	954.76M
Jilin Jian Yisheng Pharmaceutical	639.10M
Shanghai Universal Biotech	1.07B

Revenue Rankings